{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:49:08Z","timestamp":1793155748753,"version":"4.5.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","award":["EIA-2019\\u2013006"],"award-info":[{"award-number":["EIA-2019\\u2013006"]}],"id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100025294","name":"Research Ireland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100025294","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["CIRCLE - 101041424"],"award-info":[{"award-number":["CIRCLE - 101041424"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002081","name":"Irish Research Council","doi-asserted-by":"publisher","award":["GOIPG\/2021\/1649"],"award-info":[{"award-number":["GOIPG\/2021\/1649"]}],"id":[{"id":"10.13039\/501100002081","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejps.2025.107386","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T17:34:28Z","timestamp":1763660068000},"page":"107386","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Pulmonary delivery of siRNA lipoplexes and lipid nanoparticles using a vibrating mesh nebuliser"],"prefix":"10.1016","volume":"216","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-8477-7321","authenticated-orcid":false,"given":"Michael T.","family":"Neary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3617-7188","authenticated-orcid":false,"given":"Lianne M.","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7420-4159","authenticated-orcid":false,"given":"Ciaran O.","family":"Leime","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3164-1607","authenticated-orcid":false,"given":"Ronan","family":"MacLoughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6404-9845","authenticated-orcid":false,"given":"Brunella","family":"Grassiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6841-9686","authenticated-orcid":false,"given":"\u0141ukasz","family":"Baranowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8607-0189","authenticated-orcid":false,"given":"Piotr S.","family":"Kowalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6171-0303","authenticated-orcid":false,"given":"Abina M.","family":"Crean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6236-2977","authenticated-orcid":false,"given":"Katie B.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ejps.2025.107386_bib0001","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1177\/0885328219863291","article-title":"Mucopenetrating lipoplexes modified with PEG and hyaluronic acid for CD44-targeted local siRNA delivery to the lungs","volume":"34","author":"Almeida","year":"2019","journal-title":"J. Biomater. Appl."},{"key":"10.1016\/j.ejps.2025.107386_bib0002","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.2147\/COPD.S252435","article-title":"Nebulized therapies in copd: past, present, and the future","volume":"15","author":"Barjaktarevic","year":"2020","journal-title":"Int. J. COPD"},{"issue":"3","key":"10.1016\/j.ejps.2025.107386_bib0003","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00408-016-9875-2","article-title":"Cells and culture systems used to model the small airway epithelium","volume":"194","author":"Bhowmick","year":"2016","journal-title":"Lung"},{"issue":"6","key":"10.1016\/j.ejps.2025.107386_bib0004","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41587-021-00822-w","article-title":"Treatment of influenza and SARS-CoV-2 infections via mRNA-encoded Cas13a in rodents","volume":"39","author":"Blanchard","year":"2021","journal-title":"Nat. Biotechnol."},{"issue":"3","key":"10.1016\/j.ejps.2025.107386_bib0006","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s13346-015-0220-8","article-title":"Influence of cholesterol on liposome stability and on in vitro drug release","volume":"5","author":"Briuglia","year":"2015","journal-title":"Drug Deliv. Transl. Res."},{"issue":"38","key":"10.1016\/j.ejps.2025.107386_bib0007","doi-asserted-by":"crossref","first-page":"14639","DOI":"10.1039\/c1jm11693b","article-title":"Glutathione-mediated shedding of PEG layers based on disulfide-linked catiomers for DNA delivery","volume":"21","author":"Cai","year":"2011","journal-title":"J. Mater. Chem."},{"issue":"10","key":"10.1016\/j.ejps.2025.107386_bib0008","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.tips.2020.08.002","article-title":"Inhaled RNA Therapy: from Promise to Reality","volume":"41","author":"Chow","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"issue":"26","key":"10.1016\/j.ejps.2025.107386_bib0009","doi-asserted-by":"crossref","first-page":"11414","DOI":"10.1039\/D1NR02179F","article-title":"Multi-component bioresponsive nanoparticles for synchronous delivery of docetaxel and TUBB3 siRNA to lung cancer cells","volume":"13","author":"Conte","year":"2021","journal-title":"Nanoscale"},{"key":"10.1016\/j.ejps.2025.107386_bib0010","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10020057","article-title":"Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems","volume":"10","author":"Danaei","year":"2018","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.ejps.2025.107386_bib0011","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1089\/jamp.2017.1364","article-title":"Hybrid lipid\/polymer nanoparticles for pulmonary delivery of siRNA: development and fate upon in vitro deposition on the human epithelial airway barrier","volume":"31","author":"D\u2019Angelo","year":"2018","journal-title":"J. Aerosol. Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.ejps.2025.107386_bib63","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.phrs.2018.10.016","article-title":"Gene silencing of receptor-interacting protein 2 protects against cigarette smoke-induced acute lung injury","volume":"139","author":"Dong","year":"2019","journal-title":"Pharmacol Res"},{"issue":"1\u20132","key":"10.1016\/j.ejps.2025.107386_bib0012","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ijpharm.2012.06.064","article-title":"Nebulization of ultradeformable liposomes: the influence of aerosolization mechanism and formulation excipients","volume":"436","author":"Elhissi","year":"2012","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejps.2025.107386_bib0013","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/08982100903085150","article-title":"Generation of liposome aerosols with the Aeroneb Pro and the AeroProbe nebulizers","volume":"20","author":"Gaspar","year":"2010","journal-title":"J. Liposome Res."},{"issue":"1\u20132","key":"10.1016\/j.ejps.2025.107386_bib0014","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijpharm.2007.02.035","article-title":"The influence of fluid physicochemical properties on vibrating-mesh nebulization","volume":"339","author":"Ghazanfari","year":"2007","journal-title":"Int. J. Pharm."},{"issue":"8","key":"10.1016\/j.ejps.2025.107386_bib0015","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13081281","article-title":"In vitro investigations on optimizing and nebulization of ivt-mrna formulations for potential pulmonary-based alpha-1-antitrypsin deficiency treatment","volume":"13","author":"Guan","year":"2021","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.ejps.2025.107386_bib0016","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202013243","article-title":"Delivery of oligonucleotide-based therapeutics: challenges and opportunities","volume":"13","author":"Hammond","year":"2021","journal-title":"EMBo Mol. Med."},{"issue":"4","key":"10.1016\/j.ejps.2025.107386_bib0017","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/08982104.2014.992024","article-title":"siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes","volume":"25","author":"Hattori","year":"2015","journal-title":"J. Liposome Res."},{"issue":"2","key":"10.1016\/j.ejps.2025.107386_bib0018","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ejpb.2014.03.001","article-title":"That\u2019s cool! - Nebulization of thermolabile proteins with a cooled vibrating mesh nebulizer","volume":"87","author":"Hertel","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"7","key":"10.1016\/j.ejps.2025.107386_bib0019","doi-asserted-by":"crossref","DOI":"10.3390\/nano10071248","article-title":"In Vitro and In Vivo Assessment of PEGylated PEI for Anti-IL-8\/CxCL-1 siRNA Delivery to the Lungs","volume":"10","author":"Hibbitts","year":"2020","journal-title":"Nanomaterials"},{"issue":"12","key":"10.1016\/j.ejps.2025.107386_bib0020","doi-asserted-by":"crossref","first-page":"6184","DOI":"10.1021\/acs.molpharmaceut.3c00596","article-title":"Synthesis and characterization of paclitaxel-loaded PEGylated liposomes by the microfluidics method","volume":"20","author":"Jaradat","year":"2023","journal-title":"Mol. Pharm."},{"issue":"7","key":"10.1016\/j.ejps.2025.107386_bib0021","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1039\/c2lc40052a","article-title":"Interfacial organic synthesis in a simple droplet-based microfluidic system","volume":"12","author":"Ji","year":"2012","journal-title":"Lab. Chip."},{"issue":"6","key":"10.1016\/j.ejps.2025.107386_bib0022","first-page":"15","article-title":"Machine learning-assisted microfluidic approach for broad-spectrum liposome size control","author":"Jia","year":"2025","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.ejps.2025.107386_bib0023","article-title":"Combinatorial development of nebulized mRNA delivery formulations for the lungs","author":"Jiang","year":"2023","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.ejps.2025.107386_bib0024","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jconrel.2015.12.032","article-title":"Materials for non-viral intracellular delivery of messenger RNA therapeutics","volume":"240","author":"Kauffman","year":"2016","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.ejps.2025.107386_bib0025","article-title":"T-cell targeted pulmonary siRNA delivery for the treatment of asthma","volume":"12","author":"Keil","year":"2020","journal-title":"Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnology"},{"issue":"9","key":"10.1016\/j.ejps.2025.107386_bib0026","doi-asserted-by":"crossref","first-page":"14792","DOI":"10.1021\/acsnano.2c05647","article-title":"Engineering Lipid Nanoparticles for Enhanced Intracellular Delivery of mRNA through Inhalation","volume":"16","author":"Kim","year":"2022","journal-title":"ACS. Nano"},{"issue":"5","key":"10.1016\/j.ejps.2025.107386_bib0027","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s12195-020-00619-y","article-title":"Naturally Derived Membrane Lipids Impact Nanoparticle-Based Messenger RNA Delivery","volume":"13","author":"Kim","year":"2020","journal-title":"Cell Mol. Bioeng."},{"key":"10.1016\/j.ejps.2025.107386_bib0028","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/PL00022055","article-title":"Iloprost-containing liposomes for aerosol application in pulmonary arterial hypertension: formulation aspects and stability","volume":"24","author":"Kleemann","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2025.107386_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemphys.2021.111192","article-title":"Degradation of lipid based drug delivery formulations during nebulization","volume":"547","author":"Klein","year":"2021","journal-title":"Chem. Phys."},{"key":"10.1016\/j.ejps.2025.107386_bib0030","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.2147\/IJN.S136426","article-title":"Effect of the nanoformulation of siRNA-lipid assemblies on their cellular uptake and immune stimulation","volume":"12","author":"Kubota","year":"2017","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.ejps.2025.107386_bib0031","doi-asserted-by":"crossref","DOI":"10.1186\/1477-3155-11-1","article-title":"Magnetic core-shell nanoparticles for drug delivery by nebulization","volume":"11","author":"Verma","year":"2013","journal-title":"J. Nanobiotechnology"},{"issue":"2","key":"10.1016\/j.ejps.2025.107386_bib0032","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","article-title":"Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues","volume":"61","author":"Lai","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.ejps.2025.107386_bib0033","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.ejpb.2014.10.009","article-title":"Impact of atomization technique on the stability and transport efficiency of nebulized liposomes harboring different surface characteristics","volume":"88","author":"Lehofer","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"28","key":"10.1016\/j.ejps.2025.107386_bib0034","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jpcb.5b02891","article-title":"Microfluidic mixing: a general method for encapsulating macromolecules in lipid nanoparticle systems","volume":"119","author":"Leung","year":"2015","journal-title":"Journal of Physical Chemistry"},{"issue":"1","key":"10.1016\/j.ejps.2025.107386_bib0035","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jconrel.2013.12.007","article-title":"Enhanced endosomal\/lysosomal escape by distearoyl phosphoethanolamine- polycarboxybetaine lipid for systemic delivery of siRNA","volume":"176","author":"Li","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2025.107386_bib0036","first-page":"751","article-title":"Barriers and Strategies of Cationic Liposomes for Cancer Gene Therapy","volume":"18","author":"Liu","year":"2020"},{"issue":"9","key":"10.1016\/j.ejps.2025.107386_bib0037","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/s41551-021-00786-x","article-title":"Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs","volume":"5","author":"Lokugamage","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.ejps.2025.107386_bib0038","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejpb.2019.08.013","article-title":"A novel microfluidic-based approach to formulate size-tuneable large unilamellar cationic liposomes: formulation, cellular uptake and biodistribution investigations","volume":"143","author":"Lou","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"4","key":"10.1016\/j.ejps.2025.107386_bib0039","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1089\/jamp.2008.0717","article-title":"Optimized Aerosol Delivery to a Mechanically Ventilated Rodent","volume":"22","author":"MacLoughlin","year":"2009","journal-title":"J. Aerosol. Med. Pulm. Drug Deliv."},{"issue":"6","key":"10.1016\/j.ejps.2025.107386_bib62","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1089\/jamp.2011-0966","article-title":"Characterization and application of a nose-only exposure chamber for inhalation delivery of liposomal drugs and nucleic acids to mice","volume":"26","author":"Mainelis","year":"2013","journal-title":"J. Aerosol. Med. Pulm. Drug. Deliv."},{"issue":"6","key":"10.1016\/j.ejps.2025.107386_bib0040","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/aps.2017.34","article-title":"Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities","volume":"38","author":"Mangal","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"issue":"6","key":"10.1016\/j.ejps.2025.107386_bib0041","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1517\/17425247.2015.995087","article-title":"Nebulizers for drug delivery to the lungs","volume":"12","author":"Martin","year":"2015","journal-title":"Expert. Opin. Drug Deliv."},{"issue":"1","key":"10.1016\/j.ejps.2025.107386_bib0042","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-70680-4","article-title":"Impact of mixing and shaking on mRNA-LNP drug product quality characteristics","volume":"14","author":"Matthessen","year":"2024","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.ejps.2025.107386_bib0043","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1089\/nat.2022.0049","article-title":"Aerosolized pulmonary delivery of mRNA constructs attenuates severity of Escherichia coli pneumonia in the rat","volume":"33","author":"McCarthy","year":"2023","journal-title":"Nucleic. Acid. Ther."},{"issue":"3","key":"10.1016\/j.ejps.2025.107386_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103505","article-title":"Design of lipid-based nanoparticles for delivery of therapeutic nucleic acids","volume":"28","author":"Mendon\u00e7a","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejps.2025.107386_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123050","article-title":"Optimization of formulation and atomization of lipid nanoparticles for the inhalation of mRNA","volume":"640","author":"Miao","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107386_bib0046","article-title":"mRNA vaccine for cancer immunotherapy","volume":"20","author":"Miao","year":"2021"},{"key":"10.1016\/j.ejps.2025.107386_bib0047","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.jconrel.2023.12.012","article-title":"Nebulised delivery of RNA formulations to the lungs: from aerosol to cytosol","volume":"366","author":"Neary","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2025.107386_bib0048","article-title":"Lipid nanoparticles for RNA delivery: self-assembling vs driven-assembling strategies","volume":"208","author":"Nele","year":"2024"},{"key":"10.1016\/j.ejps.2025.107386_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114266","article-title":"Lipid nanoparticles for local delivery of mRNA to the respiratory tract: effect of PEG-lipid content and administration route","volume":"198","author":"Ongun","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2025.107386_bib0050","unstructured":"Panalytical, M. (2023). Zetasizer Advance Series User Guide. www.malvernpanalytical.com."},{"key":"10.1016\/j.ejps.2025.107386_bib0051","article-title":"Coating Materials to Increase the Stability of Liposomes","volume":"15","author":"Pasarin","year":"2023"},{"issue":"6","key":"10.1016\/j.ejps.2025.107386_bib0052","doi-asserted-by":"crossref","first-page":"708","DOI":"10.4187\/respcare.06290","article-title":"Aerosol delivery devices for obstructive lung diseases","volume":"63","author":"Pleasants","year":"2018","journal-title":"Respir. Care"},{"issue":"8","key":"10.1016\/j.ejps.2025.107386_bib0054","doi-asserted-by":"crossref","first-page":"7572","DOI":"10.1021\/acsnano.7b04734","article-title":"Next-generation lipids in RNA interference therapeutics","volume":"11","author":"Rietwyk","year":"2017","journal-title":"ACS. Nano"},{"key":"10.1016\/j.ejps.2025.107386_bib0055","doi-asserted-by":"crossref","DOI":"10.1038\/srep27494","article-title":"Purification of nanoparticles by size and shape","volume":"6","author":"Robertson","year":"2016","journal-title":"Sci. Rep."},{"issue":"1\u20132","key":"10.1016\/j.ejps.2025.107386_bib0056","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ijpharm.2013.07.024","article-title":"Nebulised siRNA encapsulated crosslinked chitosan nanoparticles for pulmonary delivery","volume":"455","author":"Sharma","year":"2013","journal-title":"Int. J. Pharm."},{"issue":"14","key":"10.1016\/j.ejps.2025.107386_bib0057","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.1039\/D4NA01034E","article-title":"RNA lipid nanoparticles stabilized during nebulization through excipient selection","volume":"7","author":"Slaughter","year":"2025","journal-title":"Nanoscale Adv."},{"key":"10.1016\/j.ejps.2025.107386_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.111793","article-title":"Influence of liposomes composition on their stability during the nebulization process by vibrating mesh nebulizer","volume":"204","author":"Szabov\u00e1","year":"2021","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"1","key":"10.1016\/j.ejps.2025.107386_bib0059","first-page":"121","article-title":"Apoptosis of A549 cells by small interfering RNA targeting survivin delivery using poly-\u03b2-amino ester\/guanidinylated O-carboxymethyl chitosan nanoparticles","volume":"15","author":"Tang","year":"2020","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107386_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119266","article-title":"Using microfluidics for scalable manufacturing of nanomedicines from bench to GMP: a case study using protein-loaded liposomes","volume":"582","author":"Webb","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"11","key":"10.1016\/j.ejps.2025.107386_bib0061","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12111042","article-title":"Pharmaceutics aerosolizable lipid nanoparticles for pulmonary delivery of mRNA through design of experiments","volume":"12","author":"Zhang","year":"2020","journal-title":"Pharmaceutics"}],"updated-by":[{"DOI":"10.1016\/j.ejps.2026.107589","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000}},{"DOI":"10.1016\/j.ejps.2026.107589","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000}}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725003835?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725003835?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T02:35:54Z","timestamp":1786070154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098725003835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":61,"alternative-id":["S0928098725003835"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107386","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary delivery of siRNA lipoplexes and lipid nanoparticles using a vibrating mesh nebuliser","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107386","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107386"}}